Allergan, a global pharmaceutical company headquartered in Ireland, will produce eye care products in Turkey as part of a joint project with Abdi Ibrahim, according to a report by Turkish daily Habertürk.

Ireland-based pharmaceutical and medical device manufacturer Allergan will produce eye care products in Turkey with an investment of TL 100 million ($28.72 million).

Speaking at a press conference, Marc Princen, executive vice president and president of international business at Allergan, said they have established a business partnership with Abdi İbrahim for the project. "Turkey will be the fourth country in which we have invested in technology in mass production. We will use C-RABS technology. We will have a production capacity of 9 million bottles per year. We attach great importance to Turkey," Princen added.

Explaining that they will set up a team of 180 people in Turkey, Princen also announced that the capacity increase will be carried out at Abdi Ibrahim.

"Abdi Ibrahim will use our know-how and technology," Princen said, pointing out that the products produced here will be used in Turkey in the first phase and then exported from Turkey. He also highlighted that they expect this project to be fully active by 2019.